WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

TASIMELTEON: A NOVEL DRUG IN NON-24 HOURS SLEEP WAKE DISORDER

Dr. Joonmoni Lahon*,Dr. Lalromawii , Dr. Dhriti Kr. Brahma , Dr. Julie BirdieWahlang

ABSTRACT

Free-running type or non 24 hour sleep wake disorder is a rare but chronic circadian rhythm sleep disorder (CRSD) that disrupts the sleep-wake cycle and affects the majority of totally blind individuals leading to insomnia. Tasimelteon, a melatonin receptor agonist has proved its potential as a circadian regulator that resets the biological clock in the suprachiasmatic nucleus (SCN) of the hypothalamus, thus synchronizing the body’s melatonin and cortisol circadian rhythm with the day-night cycle in patients with non 24 hour sleep wake disorder. Its potential for use in jet-lag, mood disorders and depression due to circadian rhythm disorder is under evaluation. Tasimelteon (Hetlioz) by Vanda Pharmaceuticals Inc. was approved by U.S. Food and Drug Administration (FDA) on 31st January, 2014 for treatment of non 24 sleep wake disorder.

Keywords: Tasimelteon, circadian rhythm sleep disorder, melatonin, free-running.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More